GORMAN KEVIN CHARLES bought NBIX

May 19, 2026 · Form 4 insider transaction

GORMAN KEVIN CHARLES bought 205,088 shares of Neurocrine Biosciences, Inc. at $43.24 per share, a transaction worth $8.87M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.